newsfilter
← Latest News
Business Wire·

Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its